Hui Zhong
- Hematology top 2%
- Blood groups and transfusion 8
- Platelet Disorders and Treatments 6
- Genetics top 5%
- Hemoglobinopathies and Related Disorders 11
- Immunology top 10%
- Immune Cell Function and Interaction 4
- Immune cells in cancer 3
- Physiology top 10%
- Erythrocyte Function and Pathophysiology 12
- Immunology and Allergy top 10%
-
- Heme Oxygenase-1 and Carbon Monoxide 7
-
- Neonatal Health and Biochemistry 3
- Co-authors
- Karina YazdanbakhshWeili BaoXiaojuan LiJames B. BusselDavid F. FriedmanNayla BouladDeepa ManwaniPatricia A. Shi
- Cited by
- HematologyGeneticsImmunology
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Hui Zhong
26 papers receiving 760 citations
Peers
Comparison fields: 5 of 72
- Hematology 470
- Genetics 270
- Immunology 224
- Physiology 232
- Immunology and Allergy 46
Countries citing papers authored by Hui Zhong
This map shows the geographic impact of Hui Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Zhong more than expected).
Fields of papers citing papers by Hui Zhong
This network shows the impact of papers produced by Hui Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Zhong. The network helps show where Hui Zhong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui Zhong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 8 | |
| 5 | 2022 | 19 | |
| 6 | 2021 | 32 | |
| 7 | 2019 | 9 | |
| 8 | 2019 | 6 | |
| 9 | 2019 | 1 | |
| 10 | 2019 | 35 | |
| 11 | 2018 | 41 | |
| 12 | 2018 | 1 | |
| 13 | 2015 | 58 | |
| 14 | 2014 | 56 | |
| 15 | 2014 | 5 | |
| 16 | [1,25-(OH)2D3 inhibits lipopolysaccharide-induced expression of interleukin-13 and interleukin-17 in cord blood CD4+T cells]. | 2013 | 2 |
| 17 | 2013 | 41 | |
| 18 | 2013 | 52 | |
| 19 | 2011 | 68 | |
| 20 | 2010 | 3 |
About Hui Zhong
Hui Zhong is a scholar working on Hematology, Genetics and Immunology and Allergy, having authored 28 papers that have together received 766 indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (12 papers), Hemoglobinopathies and Related Disorders (11 papers), Blood groups and transfusion (8 papers), Heme Oxygenase-1 and Carbon Monoxide (7 papers), Platelet Disorders and Treatments (6 papers), Immune Cell Function and Interaction (4 papers), Neonatal Health and Biochemistry (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Hematology (470 citations), Genetics (270 citations) and Immunology (224 citations). Hui Zhong has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Karina Yazdanbakhsh, Weili Bao, Xiaojuan Li, James B. Bussel, David F. Friedman, Nayla Boulad, Deepa Manwani, Patricia A. Shi, Sujit Sheth and Yunfeng Liu. Their work appears in journals such as Blood, American Journal of Hematology, Seminars in Hematology, Transfusion and Current Opinion in Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.